
Various checks—starting from a tape measure to stylish imaging know-how—present solely low to average settlement in diagnosing breast cancer-related lymphedema (BRCL), stories a study in Rehabilitation Oncology.
“For years, the shortage of a standardized evaluation for BRCL has been acknowledged as an obstacle to analysis and scientific practice,” feedback lead writer Cheryl L. Brunelle, PT, MS, CCS, CLT, of Massachusetts General Hospital.
“Our findings spotlight the unacceptably low ranges of settlement between totally different checks for recognizing this complication, and the pressing want to ascertain standardized diagnostic standards.”
No ‘gold commonplace’ for diagnostic checks for lymphedema
Breast cancer-related lymphedema is a sequela of breast cancer surgical procedure and lymph node radiation, characterised by uncomfortable swelling within the trunk, breast, or arm on the facet of surgical procedure. Early and correct analysis is required to allow efficient therapies for BRCL.
Although varied checks and diagnostic standards have been used, there’s nonetheless no “gold commonplace” check for figuring out sufferers with lymphedema. The authors’ hospital has launched routine lymphedema screening for girls present process breast and lymph node surgical procedure—together with measurements of arm quantity carried out earlier than and after surgical procedure.
In the brand new study, the researchers in contrast the efficiency of various checks and diagnostic standards for lymphedema. Tests included relative and absolute variations in arm quantity—assessed utilizing a tape measure—together with comparability of the handled and untreated sides, and with optoelectronic limb volumetry, which makes use of infrared gentle. The researchers additionally utilized bioimpedance spectroscopy (BIS), which makes use of very low-strength electrical present to characterize extracellular fluid ranges.

‘Clinically unacceptable’ variations between checks for BRCL
Of the 57 sufferers studied, 21 had been recognized with BCRL, primarily based on a ten% enhance in relative quantity change (RVC) from earlier than breast surgical procedure. This excessive incidence was anticipated as members with BCRL had been actively accrued. Whether preoperative baseline measures had been built-in into BCRL analysis or not, diagnostic settlement was “poor and insignificant.”
In different comparisons evaluating RVC versus optoelectronic limb volumetry or various diagnostic cutoff factors, settlement was “statistically average at finest.” Brunelle and co-authors write, “Clinically, that is unacceptable as it could end in 40% to 60% diagnostic disagreement using totally different diagnostic thresholds.”
Test efficiency diverse primarily based on the presence of bodily indicators and signs of lymphedema—particularly, swelling or a sense of “heaviness” within the arm, However, “each participant reporting heaviness or swelling met the diagnostic standards for BCRL,” the researchers write. They imagine that analysis of BRCL ought to incorporate patient-reported signs and scientific examination findings.
“The proportion of ladies recognized with BCRL after breast cancer therapy varies enormously relying on the measurement instrument and the diagnostic standards utilized,” Brunelle and co-authors conclude. They emphasize the necessity for rigorously designed research to develop standardized pointers for BRCL analysis—together with integration of preoperative baseline measurements.
More info:
Cheryl L. Brunelle et al, Agreement of Breast Cancer-Related Lymphedema Diagnosis Across Commonly Utilized Diagnostic Criteria: A Cross-Sectional Observational Cohort Study, Rehabilitation Oncology (2025). DOI: 10.1097/01.REO.0000000000000381
Citation:
Poor settlement between diagnostic checks for breast cancer-related lymphedema (15)
16
poor-agreement-diagnostic-breast-cancer.html
.
. The content material is supplied for info functions solely.
